We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 3 of 3
Most popular |Most recent


CAFC Finds ANDA Infringement Despite Differences Between FDA Labeling And Claim Language

USA - May 23 2017 In a non-precedential decision issued in Braintree Labs., Inc. v. Breckenridge Pharmaceutical, Inc., the Federal Circuit reversed the district...

Courtenay C. Brinckerhoff.

PTAB Puts Method Of Treatment Patents Under The 101 Knife

USA - February 28 2017 While the Supreme Court decisions in Myriad and Mayo have been applied to diagnostic-type claims, method of treatment patents were thought to be safe...

Jacob D. Moore, Courtenay C. Brinckerhoff, Melissa El Menaouar.

Expansion of the Patent-Ineligibility Doctrine: Are Method of Treatment Claims Patent-Eligible?

USA - February 27 2017 While Supreme Court decisions in Myriad and Mayo (and the subsequent Federal Circuit decision in Sequenom) pulled diagnostic claims under the gambit...

Melissa El Menaouar.